在临终关怀患者的预定阿片类药物管理之前和之后,有针对性的护理人员教育
Katherine G Hood1, Eve B Woodum1, Rebeccah J Collins1
1Henrico Doctors' Hospital, Richmond, VA.
HCA healthcare journal of medicine
|July 10, 2023
概括
护理教育并没有显著减少住院患者错过或延迟的阿片类药物剂量. 这项研究强调了确保终身护理的持续疼痛管理所面临的挑战,特别是在认知障碍患者中.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 疼痛管理 疼痛管理
- 护理教育 护理教育
背景情况:
- 临终关怀和息护理提高了终身患者的满意度和症状控制.
- 预定的阿片类止痛药对于治疗绝症患者的疼痛至关重要.
- 临终关怀患者的认知障碍可能导致疼痛治疗不足.
研究的目的:
- 评估护理教育对对宿舍患者服用计划性阿片类止痛药的影响.
- 评估有针对性的护理人员教育是否改善了对计划性阿片类药物治疗方案的坚持.
主要方法:
- 在社区医院的临终关怀病房进行了回顾性,准实验性研究.
- 包括已成年患者,至少有12小时的计划性阿片类药物订单.
- 干预:对非重症监护护理人员进行关于阿片类药物管理的教育.
主要成果:
- 在教育后错过 (5%对4%) 或延迟 (6%对6%) 计划中的阿片类药物剂量没有显著差异.
- 错过和延迟剂量的比例在实施前和后的队列之间在统计学上仍然相似.
- 与没有COVID-19的患者相比,COVID-19患者的阿片类药物剂量延迟率较高.
结论:
- 护理教育倡议并没有导致错过或延迟预定阿片类药物剂量的减少.
- 目前的教育策略可能不足以改善宿舍环境中阿片类药物管理的坚持.
- 需要进一步的研究来确定有效的干预措施,以优化这一群体的疼痛管理.
相关概念视频
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Documentation in Long-Term and Home Healthcare Setting
931
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
931
Nursing Process for Patient and Caregiver Teaching II: Planning and Implementation
1.3K
Planning for learning involves the development of a teaching plan. Teaching plans are similar to nursing care plans—both follow the steps of the nursing process. Planning in the teaching process involves setting goals and outcomes. Here, goals identify what a patient needs to achieve to understand a healthcare topic better, whereas the outcomes are the action to be performed by the patient to achieve the goal within a timeframe. For example, if the goal is to educate the patient about...
1.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
343
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
343
Opioid Analgesics: Morphine and Other Natural Cogeners
300
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
300
Analgesia and Pain Management
665
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
665


